Your browser doesn't support javascript.
loading
Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
Cloughesy, Tim F; Yoshimoto, Koji; Nghiemphu, Phioanh; Brown, Kevin; Dang, Julie; Zhu, Shaojun; Hsueh, Teli; Chen, Yinan; Wang, Wei; Youngkin, David; Liau, Linda; Martin, Neil; Becker, Don; Bergsneider, Marvin; Lai, Albert; Green, Richard; Oglesby, Tom; Koleto, Michael; Trent, Jeff; Horvath, Steve; Mischel, Paul S; Mellinghoff, Ingo K; Sawyers, Charles L.
Affiliation
  • Cloughesy TF; Department of Neurology, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
PLoS Med ; 5(1): e8, 2008 Jan 22.
Article in En | MEDLINE | ID: mdl-18215105

Full text: 1 Database: MEDLINE Main subject: Protein Kinases / Brain Neoplasms / Salvage Therapy / Glioblastoma / Sirolimus / Protein Kinase Inhibitors / PTEN Phosphohydrolase / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies / Qualitative_research Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2008 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Protein Kinases / Brain Neoplasms / Salvage Therapy / Glioblastoma / Sirolimus / Protein Kinase Inhibitors / PTEN Phosphohydrolase / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies / Qualitative_research Language: En Journal: PLoS Med Journal subject: MEDICINA Year: 2008 Type: Article Affiliation country: United States